Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Journal of Surgical Oncology|June 8, 2018
Prognostic value of intra-tumoral CD8<sup>+</sup> /FoxP3<sup>+</sup> lymphocyte ratio in patients with resected colorectal cancer liver metastasisKostandinos Sideras, Boris Galjart, Angela Vasaturo, et al.
British Journal of Cancer|May 19, 2020
Enrichment of the tumour immune microenvironment in patients with desmoplastic colorectal liver metastasisDiederik J Höppener, Pieter M H Nierop, Joost Hof, et al.
Antimicrobial Agents and Chemotherapy|March 2, 2016
Cross Talk between Nucleotide Synthesis Pathways with Cellular Immunity in Constraining Hepatitis E Virus ReplicationYijin Wang, Wenshi Wang, Lei Xu, et al.
Oncoimmunology|October 10, 2022
Systemic T-cell and humoral responses against cancer testis antigens in hepatocellular carcinoma patientsLisanne Noordam, Monique T A de Beijer, Shanta Mancham, et al.
European Journal of Internal Medicine|December 25, 2021
Real-life data on the impact of successful downstaging in patients with hepatocellular carcinoma: A Dutch Multicenter StudyAnnelotte G C Broekhoven, Marta Fiocco, Dave Sprengers, et al.
European Journal of Gastroenterology & Hepatology|December 3, 2015
Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers: results from a large cohort in the NetherlandsSuzanne van Meer, Karel J van Erpecum, Dave Sprengers, et al.
Cancers|June 2, 2021
Expression of Cancer Testis Antigens in Tumor-Adjacent Normal Liver Is Associated with Post-Resection Recurrence of Hepatocellular CarcinomaLisanne Noordam, Zhouhong Ge, Hadiye Özturk, et al.
Antimicrobial Agents and Chemotherapy|August 16, 2017
Inhibition of Calcineurin or IMP Dehydrogenase Exerts Moderate to Potent Antiviral Activity against Norovirus ReplicationWen Dang, Yuebang Yin, Yijin Wang, et al.
Cells|January 18, 2020
Mitochondrial Fusion Via OPA1 and MFN1 Supports Liver Tumor Cell Metabolism and GrowthMeng Li, Ling Wang, Yijin Wang, et al.
Carcinogenesis|October 6, 2018
Modeling liver cancer and therapy responsiveness using organoids derived from primary mouse liver tumorsWanlu Cao, Jiaye Liu, Ling Wang, et al.
Pageof 9